mucus relief dm extended release caplets maximum strength
Generic: guaifenesin, dextromethorphan hbr
Labeler: dolgencorp, inc. (dollar general & rexall)Drug Facts
Product Profile
Brand Name
mucus relief dm extended release caplets maximum strength
Generic Name
guaifenesin, dextromethorphan hbr
Labeler
dolgencorp, inc. (dollar general & rexall)
Dosage Form
TABLET
Routes
Active Ingredients
dextromethorphan hydrobromide 60 mg/1, guaifenesin 1200 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
55910-634
Product ID
55910-634_366a659b-0fe9-485e-a818-f6ace28f6690
Product Type
HUMAN OTC DRUG
Marketing Category
ANDA
Application Number
ANDA209692
Marketing Start
2019-02-28
Marketing End
2026-12-28
Pharmacologic Class
Established (EPC)
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
55910634
Hyphenated Format
55910-634
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
mucus relief dm extended release caplets maximum strength (source: ndc)
Generic Name
guaifenesin, dextromethorphan hbr (source: ndc)
Application Number
ANDA209692 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 60 mg/1
- 1200 mg/1
Packaging
- 7 BLISTER PACK in 1 CARTON (55910-634-07) / 1 TABLET in 1 BLISTER PACK
- 14 BLISTER PACK in 1 CARTON (55910-634-14) / 1 TABLET in 1 BLISTER PACK
Packages (2)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "366a659b-0fe9-485e-a818-f6ace28f6690", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "upc": ["0359726734080"], "unii": ["9D2RTI9KYH", "495W7451VQ"], "rxcui": ["1099074"], "spl_set_id": ["62cd2d77-abcb-4848-8d17-cf8c67216373"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "7 BLISTER PACK in 1 CARTON (55910-634-07) / 1 TABLET in 1 BLISTER PACK", "package_ndc": "55910-634-07", "marketing_end_date": "20261228", "marketing_start_date": "20190228"}, {"sample": false, "description": "14 BLISTER PACK in 1 CARTON (55910-634-14) / 1 TABLET in 1 BLISTER PACK", "package_ndc": "55910-634-14", "marketing_end_date": "20261228", "marketing_start_date": "20190228"}], "brand_name": "Mucus Relief DM Extended Release Caplets Maximum Strength", "product_id": "55910-634_366a659b-0fe9-485e-a818-f6ace28f6690", "dosage_form": "TABLET", "pharm_class": ["Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]", "Sigma-1 Agonist [EPC]", "Sigma-1 Receptor Agonists [MoA]", "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]", "Uncompetitive NMDA Receptor Antagonists [MoA]"], "product_ndc": "55910-634", "generic_name": "Guaifenesin, Dextromethorphan HBr", "labeler_name": "Dolgencorp, Inc. (DOLLAR GENERAL & REXALL)", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Mucus Relief DM Extended Release Caplets", "brand_name_suffix": "Maximum Strength", "active_ingredients": [{"name": "DEXTROMETHORPHAN HYDROBROMIDE", "strength": "60 mg/1"}, {"name": "GUAIFENESIN", "strength": "1200 mg/1"}], "application_number": "ANDA209692", "marketing_category": "ANDA", "marketing_end_date": "20261228", "marketing_start_date": "20190228"}